IPO registrations (S-1, F-1) · Registrants
PRA International, LLC
- SEC CIK
- 1293243 · filings on EDGAR ↗
- Name on the registration
- PRA International
- Former names
- PRA International (2004–2007)
- Registration
- Form S-1, first filed 2004-06-14, last 2005-06-14; 2 initial registrations, 7 amendments
- Outcome
- Final prospectus filed 2004-11-18
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 4131 PARKLAKE AVENUE, SUITE 600, Raleigh, NC 27612
- EIN
- 54-2040171
- EDGAR entity type
- operating
- Insiders and CEO pay
- PRA International, LLC on the corporate pages
Offering terms
- Proposed price range
- $16.00–$18.00 per share (S-1/A filed 2004-11-16)
- Final price
- $19.00 per share, above the range (424B4 filed 2004-11-18, an initial public offering)
- Shares sold
- 6,000,000 (3,600,000 by the company, 2,400,000 by selling holders)
- Gross proceeds
- $114,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol PRAI
- Lead underwriters
- Credit Suisse
- Syndicate
- Bear Stearns; William Blair; Jefferies
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Federal award recipient: PRA INTERNATIONAL, LLC Fuzzy (name and state)
- SEC filer: PRA International EXACT (CIK (EXACT))
- Person page: Gregory P Spivy Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 12
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2004-06-14 | S-1 | S-1 (registration) | PRA International | 0000950133-04-002380 ↗ |
| 2004-07-29 | S-1/A | S-1/A (amendment) | PRA International | 0000950133-04-002921 ↗ |
| 2004-09-21 | S-1/A | S-1/A (amendment) | PRA International | 0000950133-04-003558 ↗ |
| 2004-10-22 | S-1/A | S-1/A (amendment) | PRA International | 0000950133-04-003875 ↗ |
| 2004-10-28 | S-1/A | S-1/A (amendment) | PRA International | 0000950133-04-003960 ↗ |
| 2004-11-16 | S-1/A | S-1/A (amendment) | PRA International | 0000950133-04-004335 ↗ |
| 2004-11-18 | 424B4 | 424B4 (final prospectus) | PRA International | 0000950133-04-004382 ↗ |
| 2005-05-17 | S-1 | S-1 (registration) | PRA International | 0000950133-05-002284 ↗ |
| 2005-05-27 | S-1/A | S-1/A (amendment) | PRA International | 0000950133-05-002425 ↗ |
| 2005-06-14 | S-1/A | S-1/A (amendment) | PRA International | 0000950133-05-002653 ↗ |
| 2005-06-15 | S-1MEF | S-1MEF (added securities) | PRA International | 0000950133-05-002670 ↗ |
| 2005-06-16 | 424B4 | 424B4 (final prospectus) | PRA International | 0000950133-05-002686 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2004-11-16 | S-1/A | registration statement | $16.00–$18.00 | 6,000,000 | - | Nasdaq PRAI | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2004-11-18 | 424B4 | final prospectus | $19.00 | 6,000,000 | $114,000,000 | Nasdaq PRAI | 4 | primary document; price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Donnelly Patrick K | Director,Officer; Other | President and CEO | 7 | 2006 | |
| Bond J Matthew | Officer | EVP, Chief Financial Officer; SVP, Chief Financial Officer | 3 | 2006 | |
| KESSLER ARMIN M | Director | 3 | 2006–2007 | ||
| Pietrek Monika | Officer | EVP Global Sci & Med Affs; EVP, Global Sci. & Med. Affs. | 11 | 2006–2007 | |
| Powers James C | Officer | EVP Wldwide Bus. Dev.; EVP Wldwide Bus. Dev., Sectry | 8 | 2006 | |
| Walsh William M III | Officer | EVP Bus. Ser., Strategic Prog; EVP Corp Dev., Secretary; SVP Bus. Ser., Strategic Prog | 17 | 2006–2007 | |
| Dockhorn David W | Officer | EVP Global Clinical Operations; EVP Product Reg. The Americas | 9 | 2006–2007 | |
| OMullan Gail | Officer | SVP, Talent Management | 3 | 2006 | |
| Teplitzky Bruce | Officer | EVP, Business Development | 7 | 2006–2007 | |
| KAMIN PETER H | TenPercentOwner | 10 | 2006–2007 | ||
| UBBEN JEFFREY W | TenPercentOwner | 10 | 2006–2007 | ||
| ValueAct Capital Management, LLC | TenPercentOwner | 11 | 2006–2007 | ||
| ValueAct Capital Management, L.P. | TenPercentOwner | 11 | 2006–2007 | ||
| VA PARTNERS LLC | TenPercentOwner | 10 | 2006–2007 | ||
| Drijfhout Willem Jan | Officer | SVP Early Development Studies; SVP, Early Development Svcs | 4 | 2006–2007 | |
| BOOTH MELVIN D | Director; DirectorOther | 4 | 2006–2007 | ||
| CONWAY ROBERT | Director | 3 | 2006–2007 | ||
| HEMBERGER JUDITH A | Director | 2 | 2006–2007 | ||
| BIEKER TERRANCE J | Director,Officer | Chief Executive Officer; Interim CEO | 5 | 2006–2007 | |
| VA Partners III, LLC | TenPercentOwner | 6 | 2006–2007 | ||
| SHANNON COLIN | Officer | Pres/Chief Operating Officer | 3 | 2007 | |
| BADDOUR LINDA | Officer | EVP and CFO | 4 | 2007 | |
| Spivy Gregory P | Director | 3 | 2007 | person page Fuzzy | |
| Stansfield Susan Caroline | Officer | Executive Vice President | 3 | 2007 | |
| ValueAct Holdings GP, LLC | TenPercentOwner | 2 | 2007 | ||
| ValueAct Holdings, L.P. | TenPercentOwner | 2 | 2007 | ||
| VA Partners I, LLC | TenPercentOwner | 2 | 2007 | ||
| CONTE JEAN PIERRE | Other | 1 | 2007 | ||
| Genstar Capital III, L.P. | Other | 1 | 2007 | ||
| Genstar Capital Partners III, L.P. | Other | 1 | 2007 | ||
| GENSTAR III GP LLC | Other | 1 | 2007 | ||
| Stargen III, L.P. | Other | 1 | 2007 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | PRA INTERNATIONAL | NC | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | PRA INTERNATIONAL, LLC | NC | Federal spending (USAspending) | name and state |
| SEC filer | PRA International | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Gregory P Spivy | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, NC first:
- Icoria, Inc. NC
- INVERESK RESEARCH GROUP INC NC
- IQVIA HOLDINGS INC. NC
- Icagen, Inc. NC
- Syneos Health, Inc. NC
- PRA Health Sciences, Inc. NC
- PPD, Inc. NC
- Science 37 Holdings, Inc. NC
- WEED, INC. AZ
- GLYCOTEX, INC. C3
In other datasets, the same topic (Medical research) in NC:
- Form D issuer: 22nd Century Group, Inc. (Form D private offerings)
- Nonprofit: 3000 MILES FOR AUTISM (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research